Andrew H. Zabolotsky
Andrew H. Zabolotsky publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Gallbladder and Bile Duct Disorders, Esophageal and GI Pathology and Gastrointestinal Tumor Research and Treatment.
- World rank
- #5,135,742 of 7,710,434 ranked researchers
- Rank in United States
- #1,322,794 of 1,627,098
- Works
- 16
- Citations
- 114
- Citations per work
- 7.1
What does Andrew H. Zabolotsky research?
Andrew H. Zabolotsky's work is mostly in Medicine (82%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1381.5%
- Medicine1381.5%
- Everything else318.5%
- 1Surgery28% of their works
- 2Pulmonary and Respiratory Medicine21% of their works
- 3Oncology14% of their works
- 4Gastroenterology9% of their works
- 5Cardiology and Cardiovascular Medicine5% of their works
- 6Dermatology5% of their works
Research topics
- Gallbladder and Bile Duct Disorders
- Esophageal and GI Pathology
- Gastrointestinal Tumor Research and Treatment
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Organ Transplantation Techniques and Outcomes
- Pediatric Hepatobiliary Diseases and Treatments
Which keywords describe Andrew H. Zabolotsky's research?
The keywords of their largest research topics: Chemotherapy, Cholecystitis, Clinical Practice Guidelines, ERCP, Endoscopic Stenting, Esophageal Perforation, Liver Transplantation and Neoadjuvant Therapy.
- Surgical Complications
- Preoperative Chemoradiotherapy
- Ischemia-Reperfusion Injury
- Biliary Atresia
- Sunitinib
- Gastric Cancer
- Neoadjuvant Therapy
- Esophageal Perforation
- ERCP
- Cholecystitis
- Chemotherapy
- Clinical Practice Guidelines
- Endoscopic Stenting
- Liver Transplantation
- Endoscopic Resection
- Imatinib Mesylate
- Alagille Syndrome
- Graft Survival
- Pancreatic Cancer
- Rectal Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy52 topics
- Cholecystitis51 topic
- Clinical Practice Guidelines52 topics
- ERCP51 topic
- Endoscopic Stenting41 topic
- Esophageal Perforation41 topic
- Liver Transplantation42 topics
- Neoadjuvant Therapy42 topics
- Endoscopic Resection31 topic
- Gastric Cancer31 topic
- Imatinib Mesylate31 topic
- Sunitinib31 topic
- Alagille Syndrome21 topic
- Biliary Atresia21 topic
- Graft Survival21 topic
- Ischemia-Reperfusion Injury21 topic
- Pancreatic Cancer21 topic
- Preoperative Chemoradiotherapy21 topic
- Rectal Cancer21 topic
- Surgical Complications21 topic
Where does Andrew H. Zabolotsky work?
Andrew H. Zabolotsky's main affiliation in the publication record is Thomas Jefferson University Hospital, United States.
How many publications and citations does Andrew H. Zabolotsky have?
OpenAlex counts 16 works and 114 citations for Andrew H. Zabolotsky, an h-index of 4, ranking #5,135,742 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Andrew H. Zabolotsky. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.